Short Interest in Cocrystal Pharma, Inc. (NASDAQ:COCP) Increases By 150.0%

Cocrystal Pharma, Inc. (NASDAQ:COCP) saw a large increase in short interest in December. As of December 15th, there was short interest totalling 17,500 shares, an increase of 150.0% from the November 30th total of 7,000 shares. Based on an average trading volume of 24,300 shares, the short-interest ratio is presently 0.7 days. Approximately 0.3% of the shares of the stock are short sold.

Cocrystal Pharma Trading Up 24.6 %

Shares of COCP opened at $3.09 on Friday. Cocrystal Pharma has a 12-month low of $1.33 and a 12-month high of $3.10. The company’s 50-day moving average price is $2.04 and its 200 day moving average price is $2.02. The firm has a market cap of $31.44 million, a P/E ratio of -1.67 and a beta of 1.52.

Cocrystal Pharma Company Profile

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.